dr. woyach on the design of the ongoing alliance a041702 trial in cll
Published 4 years ago • 96 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
0:55
dr. woyach on the results of the elevate-tn trial
-
1:03
dr. woyach on the safety of acalabrutinib versus ibrutinib in cll
-
1:25
dr. woyach on the role of chemoimmunotherapy in cll
-
1:17
dr. woyach on treatment challenges in cll
-
1:47
dr. woyach on ibrutinib resistance in cll
-
1:20
dr. woyach on 3-year follow-up of acalabrutinib/obinutuzumab combo in cll
-
1:17
dr. woyach discusses progression on ibrutinib with the acquisition of resistance mutations
-
1:37
woyach on the safety profiles of btk inhibitors in cll
-
0:40
dr. woyach discusses efficacy findings from the resonate trial
-
0:28
dr. woyach discusses the efficacy findings from the resonate trial
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
1:46
dr. woyach on frontline treatment options in cll
-
0:49
dr. woyach on preliminary efficacy results of mor208 trial in cll
-
1:31
dr. woyach discusses progression on ibrutinib with the acquisition of resistance mutations
-
1:26
dr. woyach discusses peripheral lymphocytosis in patients with cll taking ibrutinib
-
1:46
better ibrutinib combinations being explored in a clinical trial
-
6:18
jennifer a. woyach: results of alliance north american intergroup study a041202
-
2:21
uk-based cll clinical trials to look forward to
-
1:06
dr. woyach on ibrutinib regimens in frontline cll